Showing results (1991-2000 of 2,453) with videos related to
Sort By:
Pageof 246
Clinical and Translational Science|December 17, 2024
Association of liver fibrosis scores with all-cause and cardiovascular mortality in patients with heart failureZiyu Guo, Zixiang Ye, Qinfeng Xu, et al.Clinical and Translational Science|December 23, 2024
Safety of BI 1358894 in patients with major depressive disorder: Results and learnings from a phase II randomized decentralized clinical trialChristopher Reist, Peide Li, Thuy Le Nguyen, et al.Clinical and Translational Science|December 16, 2024
Longitudinal correlation of cerebrospinal fluid GFAP and the progression of cognition decline in different clinical subtypes of Parkinson's diseaseYumei Liu, Jing Wang, Fangbo Ning, et al.Clinical and Translational Science|December 11, 2024
An overview of drug-induced sodium channel blockade and changes in cardiac conduction: Implications for drug safetyKhuram W Chaudhary, Colleen E Clancy, Pei-Chi Yang, et al.Clinical and Translational Science|December 11, 2024
Efficacy and safety of 4-hydroxy 2-methyl-N-(5-methyl-2-thiazolyl)-2H-1, 2-benzothiazin-3-carboxamide 1,1-dioxide, a fast-acting meloxicam formulation, on moderate-to-severe pain following abdominal surgery: A phase III randomized controlled trialXiaohua Liu, Yanhua Zhao, Mengchang Yang, et al.Clinical and Translational Science|November 19, 2024
Use cases of registry-based randomized controlled trials-A review of the registries' contributions and constraintsNadine Kubesch, Sneha Gaitonde, Uarda Petriti, et al.Clinical and Translational Science|November 18, 2024
Efficacy and safety of tofacitinib in rheumatoid arthritis: Nine years of real-world dataAli Ekin, Salim Misirci, Selin İldemir, et al.Clinical and Translational Science|November 11, 2024
Safety, pharmacokinetics, and pharmacodynamics of sofnobrutinib, a novel non-covalent BTK inhibitor, in healthy subjects: First-in-human phase I studyKyoko Miyamoto, Robert M Miller, Christine Voors-Pette, et al.Clinical and Translational Science|November 13, 2024
Evaluation of drug-drug interactions of a novel potent FLT3 inhibitor SKLB1028 in healthy subjectsJingcheng Chen, Jingxuan Wu, Nini Guo, et al.Clinical and Translational Science|October 15, 2024
A "one-step" approach to heart rate correction and statistical analysis applied to conscious dog QTc studiesDerek D Best, Matthew M Abernathy, Derek J LeishmanPageof 246